Kinetics of immune response from mild, moderate to severe COVID-19 patients ranges from augmented humoral and cellular immunity to lymphopenia affecting CD4+ T cells, CD8+ T cells, B cells and natural killer cells [46,47,48,49]. This evidence concerns the gene CD4 and lymphopenia.